Holders of marketing authorisations should be proactively responsible for on-going pharmacovigilance of the medicinal products they place on the market.
Recital 58, Directive (EU) 2001/83
In force
Holders of marketing authorisations should be proactively responsible for on-going pharmacovigilance of the medicinal products they place on the market.